HR 466
103th Congress
House
Foreign Trade and International Finance
Breast cancer
Chemotherapy
Drugs
Tariff
To extend until January 1, 1996, the existing suspension of duty on tamoxifen citrate.
Everywhere this bill has been
6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 28, 1994
See H.R.5110.
Jul 28, 1993
Executive Comment Received from ITC.
Apr 12, 1993
Executive Comment Requested from Treasury, Commerce, ITC, USTR.
Jan 15, 1993
Referred to the Subcommittee on Trade.
Jan 6, 1993
Referred to the House Committee on Ways and Means.
Jan 6, 1993
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Amends the Harmonized Tariff Schedule of the United States to extend, through December 31, 1995, the suspension of duty on tamoxifen citrate.
What's happening now
See H.R.5110.
Related & companion bills
2
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
3
Cite this page
U.S. Congress. (2026). H.R. 466: To extend until January 1, 1996, the existing suspension of duty on tamoxifen citrate.. 103rd Congress. Open America. https://openamerica.io/bill/103-HR-466/
"H.R. 466: To extend until January 1, 1996, the existing suspension of duty on tamoxifen citrate.." 103rd Congress, 2026, Open America, https://openamerica.io/bill/103-HR-466/.
H.R. 466, 103rd Cong. (2026), https://openamerica.io/bill/103-HR-466/.
[H.R. 466: To extend until January 1, 1996, the existing suspension of duty on tamoxifen citrate.](https://openamerica.io/bill/103-HR-466/)